These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 12746772

  • 1. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.
    Urban C, Segal-Maurer S, Rahal JJ.
    Clin Infect Dis; 2003 May 15; 36(10):1268-74. PubMed ID: 12746772
    [Abstract] [Full Text] [Related]

  • 2. Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study.
    Lee NY, Wang CL, Chuang YC, Yu WL, Lee HC, Chang CM, Wang LR, Ko WC.
    Pharmacotherapy; 2007 Nov 15; 27(11):1506-11. PubMed ID: 17963460
    [Abstract] [Full Text] [Related]

  • 3. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
    Sayin Kutlu S, Saçar S, Süzer T, Cevahir N, Okke D, Dirgen Caylak S, Turgut H.
    Mikrobiyol Bul; 2008 Apr 15; 42(2):353-8. PubMed ID: 18697435
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.
    Tatman-Otkun M, Gürcan S, Ozer B, Shokrylanbaran N.
    New Microbiol; 2004 Jan 15; 27(1):21-8. PubMed ID: 14964402
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
    Tong W, Wang R, Chai D, Li Z, Pei F.
    Int J Antimicrob Agents; 2006 Nov 15; 28(5):454-6. PubMed ID: 16987639
    [Abstract] [Full Text] [Related]

  • 10. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study.
    Apisarnthanarak A, Pinitchai U, Thongphubeth K, Yuekyen C, Warren DK, Fraser VJ, Thammasat University Pandrug-Resistant Acinetobacter baumannii Control Group.
    Clin Infect Dis; 2008 Sep 15; 47(6):760-7. PubMed ID: 18684100
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.
    Jain R, Danziger LH.
    Ann Pharmacother; 2004 Sep 15; 38(9):1449-59. PubMed ID: 15280512
    [Abstract] [Full Text] [Related]

  • 13. Restricting the use of ampicillin-sulbactam.
    Zavascki AP, Sandri AM.
    J Hosp Infect; 2004 Feb 15; 56(2):165-6. PubMed ID: 15019231
    [No Abstract] [Full Text] [Related]

  • 14. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
    Mastoraki A, Douka E, Kriaras I, Stravopodis G, Saroglou G, Geroulanos S.
    Eur J Cardiothorac Surg; 2008 Jun 15; 33(6):1086-90. PubMed ID: 18339553
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for multi-drug resistant Acinetobacter baumannii nosocomial infection.
    Surasarang K, Narksawat K, Danchaivijitr S, Siripanichgon K, Sujirarat D, Rongrungrueng Y, Kiratisin P.
    J Med Assoc Thai; 2007 Aug 15; 90(8):1633-9. PubMed ID: 17926995
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic options for Acinetobacter baumannii infections.
    Vila J, Pachón J.
    Expert Opin Pharmacother; 2008 Mar 15; 9(4):587-99. PubMed ID: 18312160
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, Cheong HJ.
    J Antimicrob Chemother; 2007 Aug 15; 60(2):317-22. PubMed ID: 17540672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.